Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| 1 |
Applovin
APP
|
+$810M |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
+$748M |
| 3 |
Palantir
PLTR
|
+$504M |
| 4 |
Union Pacific
UNP
|
+$391M |
| 5 |
AbbVie
ABBV
|
+$366M |
Top Sells
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.88B |
| 2 |
Meta Platforms (Facebook)
META
|
+$719M |
| 3 |
Broadcom
AVGO
|
+$683M |
| 4 |
Bank of America
BAC
|
+$675M |
| 5 |
Wells Fargo
WFC
|
+$631M |
Sector Composition
| 1 | Technology | 16.39% |
| 2 | Financials | 13.7% |
| 3 | Healthcare | 12.33% |
| 4 | Industrials | 11.64% |
| 5 | Consumer Discretionary | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1176
WSFS Financial
WSFS
$3.15B
| $17.1M | 0.01% |
311,319
+238,593
| +328% | +$13.1M |
|
1177
Erie Indemnity
ERIE
$17.7B
| $17.1M | 0.01% |
49,369
-12,615
| -20% | -$4.37M |
|
|
ETOR
1178
eToro Group Ltd. Class A Common Shares
ETOR
$3.71B
| $17.1M | 0.01% |
+256,910
| New | +$17.1M |
|
1179
BioCryst Pharmaceuticals
BCRX
$1.69B
| $17.1M | 0.01% |
1,906,667
-1,906,207
| -50% | -$17.1M |
|
1180
Leggett & Platt
LEG
$1.31B
| $17M | 0.01% |
1,907,642
-2,697,774
| -59% | -$24.1M |
|
1181
Microvast
MVST
$1.01B
| $17M | 0.01% |
4,687,392
+41,332
| +0.9% | +$150K |
|
1182
United Parks & Resorts
PRKS
$2.76B
| $17M | 0.01% |
360,172
+351,423
| +4,017% | +$16.6M |
|
1183
ESCO Technologies
ESE
$5.35B
| $17M | 0.01% |
88,413
+67,349
| +320% | +$12.9M |
|
1184
Realty Income
O
$55.1B
| $17M | 0.01% |
294,346
+249,913
| +562% | +$14.4M |
|
|
XHR
1185
Xenia Hotels & Resorts
XHR
$1.4B
| $17M | 0.01% |
1,348,484
-777,714
| -37% | -$9.78M |
|
1186
VICI Properties
VICI
$35.4B
| $16.9M | 0.01% |
519,596
+154,348
| +42% | +$5.03M |
|
1187
FirstCash
FCFS
$6.56B
| $16.9M | 0.01% |
124,974
-168,776
| -57% | -$22.8M |
|
1188
Kenvue
KVUE
$36.7B
| $16.9M | 0.01% |
806,006
-1,275,670
| -61% | -$26.7M |
|
1189
Nutrien
NTR
$27.8B
| $16.8M | 0.01% |
288,682
+242,064
| +519% | +$14.1M |
|
1190
Akero Therapeutics
AKRO
$3.55B
| $16.8M | 0.01% |
314,989
+84,125
| +36% | +$4.49M |
|
1191
Royalty Pharma
RPRX
$15.8B
| $16.8M | 0.01% |
466,431
+157,261
| +51% | +$5.67M |
|
|
BOW
1192
Bowhead Specialty Holdings
BOW
$996M
| $16.8M | 0.01% |
447,479
+197,202
| +79% | +$7.4M |
|
1193
OrthoPediatrics
KIDS
$498M
| $16.8M | 0.01% |
781,027
+124,449
| +19% | +$2.67M |
|
1194
UL Solutions
ULS
$13.7B
| $16.8M | 0.01% |
230,239
+42,049
| +22% | +$3.06M |
|
1195
Nektar Therapeutics
NKTR
$882M
| $16.8M | 0.01% |
649,033
+496,446
| +325% | +$12.8M |
|
1196
MannKind Corp
MNKD
$1.69B
| $16.8M | 0.01% |
4,481,526
-1,341,064
| -23% | -$5.02M |
|
1197
iShares Russell 2000 ETF
IWM
$67.1B
| $16.7M | 0.01% |
77,514
-727,104
| -90% | -$157M |
|
1198
Vita Coco
COCO
$2.22B
| $16.7M | 0.01% |
+463,072
| New | +$16.7M |
|
1199
Cabot Corp
CBT
$4.26B
| $16.7M | 0.01% |
222,851
-29,628
| -12% | -$2.22M |
|
1200
Life Time Group Holdings
LTH
$6.38B
| $16.7M | 0.01% |
550,535
-1,488,246
| -73% | -$45.1M |
|